The financial impact of implementation of a prehabilitation program for colorectal cancer patients in the Netherlands: A budget impact analysis

IF 2.9 2区医学 Q2 ONCOLOGY

Ejso Pub Date : 2025-08-18 DOI:10.1016/j.ejso.2025.110375

C.R. Sabajo , C.T.J. Michels , A. van der Hout , B. van den Heuvel , J.W. Dekker , J.M. Klaase , G.D. Slooter

{"title":"The financial impact of implementation of a prehabilitation program for colorectal cancer patients in the Netherlands: A budget impact analysis","authors":"C.R. Sabajo , C.T.J. Michels , A. van der Hout , B. van den Heuvel , J.W. Dekker , J.M. Klaase , G.D. Slooter","doi":"10.1016/j.ejso.2025.110375","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Prehabilitation is proven to be clinically effective, it has shown to decrease complication rate and length of hospital stay after colorectal cancer surgery. However, for broad implementation, information is needed on the financial impact of prehabilitation. This study evaluates the budget impact of a prehabilitation program for colorectal cancer surgery patients in the Netherlands.</div></div><div><h3>Methods</h3><div>This budget impact analysis was based on real world data from Dutch hospitals and available data in literature. It was assessed for a period of five years, considering an annual rate of approximately 10,500 colorectal cancer surgeries in the Netherlands. Several scenarios were assessed, varying population size, prehabilitation program cost, and uptake of prehabilitation.</div></div><div><h3>Results</h3><div>The total mean hospital admission costs per patient was €3060 for the prehabilitation program and €3636 for standard care. Calculated over a one-year period, this was €77.9 million for patients with a prehabilitation program, while the standard care costs €90.8 million.</div></div><div><h3>Conclusion</h3><div>Implementation of a prehabilitation program for colorectal cancer surgery patients in the Netherlands may reduce hospital costs. The program could generate savings of approximately €64.3 million over five years, supporting its broader adoption.</div></div>","PeriodicalId":11522,"journal":{"name":"Ejso","volume":"51 11","pages":"Article 110375"},"PeriodicalIF":2.9000,"publicationDate":"2025-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ejso","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0748798325008030","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background

Prehabilitation is proven to be clinically effective, it has shown to decrease complication rate and length of hospital stay after colorectal cancer surgery. However, for broad implementation, information is needed on the financial impact of prehabilitation. This study evaluates the budget impact of a prehabilitation program for colorectal cancer surgery patients in the Netherlands.

Methods

This budget impact analysis was based on real world data from Dutch hospitals and available data in literature. It was assessed for a period of five years, considering an annual rate of approximately 10,500 colorectal cancer surgeries in the Netherlands. Several scenarios were assessed, varying population size, prehabilitation program cost, and uptake of prehabilitation.

Results

The total mean hospital admission costs per patient was €3060 for the prehabilitation program and €3636 for standard care. Calculated over a one-year period, this was €77.9 million for patients with a prehabilitation program, while the standard care costs €90.8 million.

Conclusion

Implementation of a prehabilitation program for colorectal cancer surgery patients in the Netherlands may reduce hospital costs. The program could generate savings of approximately €64.3 million over five years, supporting its broader adoption.

查看原文本刊更多论文

实施荷兰结直肠癌患者康复计划的财务影响：预算影响分析

背景：预康复在临床上被证明是有效的，它可以减少结直肠癌手术后的并发症发生率和住院时间。但是，为了广泛实施，需要关于康复的财政影响的资料。本研究评估了荷兰结直肠癌手术患者康复计划的预算影响。方法本预算影响分析基于荷兰医院的真实数据和文献中的现有数据。这项研究的评估期为5年，考虑到荷兰每年约有10500例结直肠癌手术。评估了几种情况，不同的人口规模、康复计划成本和康复的吸收。结果康复项目的平均住院费用为3060欧元，标准治疗的平均住院费用为3636欧元。按照一年的时间计算，参加康复计划的患者的费用为7790万欧元，而标准护理费用为9080万欧元。结论在荷兰实施结直肠癌手术患者的康复计划可降低医院费用。该计划可在五年内节省约6430万欧元，支持其更广泛的采用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Ejso 医学-外科

CiteScore

6.40

自引率

2.60%

发文量

1148

审稿时长

41 days

期刊介绍： JSO - European Journal of Surgical Oncology ("the Journal of Cancer Surgery") is the Official Journal of the European Society of Surgical Oncology and BASO ~ the Association for Cancer Surgery. The EJSO aims to advance surgical oncology research and practice through the publication of original research articles, review articles, editorials, debates and correspondence.